Biocracked
Longevity Metabolism Peptides Research Supplements Trending: supplements clinical trial longevity nad+ nootropics
Approach: Macro science. Palette: D, bold color field. Extreme close-up microscopy-style photograph of a stained rat skeletal muscle cross-section, shot straight down through the microscope objective. Polygonal muscle fibers fill the frame in saturated magenta and pink eosin tones. A cluster of fibers on the left is neatly packed and uniform. On the right, the tissue is disrupted, with swollen gaps and thin, fibrous collagen strands in pale violet threading between damaged cells. A few tiny electric green fluorescent specks sit along one fiber edge as a subtle accent. Lighting is bright, even transmitted light with crisp focus at the center and soft falloff at the edges. The mood is analytical and tense, a rescue only partly complete. No text, no labels.
Peptides

BPC‑157 Nglindhungi Otot Tikus Saka Cedera Aliran Darah—Nanging Ana Syarat

Nova Chen · · 4 min read
#bpc 157 #peptides #ischemia reperfusion #muscle injury #animal study #vegf #oxidative stress

BPC‑157 Nglindhungi Otot Tikus Saka Cedera Aliran Darah—Nanging Ana Syarat

Apa sing kelakon ing otot sikil nalika aliran darah dipotong lan banjur dibalekaké kanthi cepet?

Yen aliran darah diputus lan bali maneh, otot bisa nandhang kerusakan luwih parah tinimbang saka sumbatané dhéwé. Panalitungan paling anyar ing tikus nyatakaké yèn peptida BPC‑157 saged nyuda karusakan iki. Nanging, penting kanggo eling yèn asil iki mung saka kewan lan BPC‑157 durung disetujoni dadi obat.

Ringkesan

Pitulungan riset saka Turki sing dipunbabar ing Scientific Reports (2026) nyebutaké yèn siji dosis BPC‑157 bisa ngurangi pratanda cedera otot ing tikus sawisé ngalami gangguan aliran darah sementara ing sikil mburi. Tikus sing diwènèhi peptida iki nuduhaké stres oksidatif sing luwih sithik, sinyal matine sel sing luwih endhek, lan inflamasi sing luwih lemah dibandhingaké karo kelompok kontrol. Kajaba iku, tingkat VEGF (faktor pertumbuhan pembuluh darah) pulih sakedhikipun.

Studi iki cilik lan mung dilakokaké ing model kewan; mulane asil iki ora bisa dianggep minangka rekomendasi terapi klinis.

Napa Cedera Reperfusi Penting?

Cedera iskemia‑reperfusi (I/R) yaiku komplikasi umum ing penyakit arteri perifer lan operasi vaskular. Nalika jaringan kepeké saka darah lan banjur dipunparingi aliran balik (reperfusi), oksigen sing mlebu kanthi dadakan ngasilaké radikal bebas sing akeh. Iki ndadékaké inflamasi lan apoptosis (pembunuhan sel terprogram), dadi proses sing kudune nylametaké malah nambah kerusakan.

BPC‑157 yaiku pentadecapeptida (15 asam amino) sing stabil lan asalé saka jus lambung. Ing pirang‑pirang panalitungan pra‑klinis, peptida iki nuduhaké efek sitoprotektif ing jaringan macem‑macem. Panalitungan iki nyoba apa BPC‑157 isa nglindhungi otot rangka ing model I/R sikil.

Cara Eksperimen Dilakokaké

  • Kewan: 24 tikus Wistar albino lanang, dipérang dadi papat kelompok (pitung tikus saben klompok).
  • Kelompok:
    • SHAM: operasi tanpa klamping.
    • B: mung diwènèhi BPC‑157.
    • IR: iskemia‑reperfusi tanpa perawatan.
    • IRB: iskemia‑reperfusi lan diwènèhi BPC‑157.
  • Model cedera: Aorta abdomen dipunklamp sajrone 45 menit, banjur dipunparingi reperfusi 2 jam.
  • Dosis: BPC‑157 20 µg/kg disuntik intraperitoneal ing menit ke‑45 iskemia (pungkasan periode klamping, nalika reperfusi diwiwiti).
  • Pengukuran: Tandha serum (MDA, SOD, TAS, TOS), ekspresi gen qRT‑PCR (IL‑6, HIF‑1α, p53, Bcl‑2, Bax, Casp3), imunohistokimia (VEGF, eNOS, IL‑6, caspase‑3), lan penilaian pewarnaan jaringan.

Apa Sing Ditemokaké Peneliti

Cedera I/R Bener‑bener Ana

Ing tikus IR sing ora diwènèhi perawatan, pratanda berikut nambah drastis: MDA (kerusakan lipid), total oxidant status (TOS), p53, Bax, caspase‑3, HIF‑1α, IL‑6, lan skor histopatologi. Saliyane, pratanda protektif kaya SOD, total antioxidant status (TAS), lan ekspresi VEGF mudhun.

BPC‑157 Ngganti Gambarane

Ing kelompok IRB (iskemia‑reperfusi + BPC‑157), asil sing dilaporaké yaiku:

  • Stres oksidatif luwih sithik: MDA lan TOS mudhun, dene SOD lan TAS mbalèkaké nilai normal.
  • Sinyal apoptosis luwih endhek: p53, Bax, lan Casp3 down‑regulated, lan imunoreaktivitas caspase‑3 turun. Ekspresi Bcl‑2 (gen anti‑apoptosis) luwih dhuwur tinimbang kelompok IR.
  • Inflamasi luwih lemah: imunoreaktivitas IL‑6 mudhun.
  • Sinyal angiogenesis luwih apik: ekspresi VEGF pulih sebagian.
  • Struktur jaringan luwih rapih: arsitektur otot luwih teratur lan deposit kolagen ing histologi luwih sithik.

Miturut penulis, BPC‑157 katon nglindhungi otot rangka kanthi ngurangi stres oksidatif, ngatur apoptosis, ngendhaleni inflamasi, lan ndhukung angiogenesis.

Watesan: Apa Sing Ora Bisa Dikasih Jawaban Déning Studi Iki

  1. Mung tikus. Asil saka kéwan kerep ora bisa dipindhahaké langsung menyang manungsa.
  2. Ukuran sampel cilik. Enem kewan saben klompok maringi kapercayan statistik sing winates.
  3. Siji dosis, siji wektu. Ora ana uji dose‑response, mula ora jelas apa 20 µg/kg iku dosis optimal utawa apa dosis liya bisa luwih apik.
  4. Follow‑up mung 2 jam. Mangsa reperfusi sing cendhak ora nuduhaké apa manfaaté tahan suwe utawa ndadékaké perbaikan fungsi sikil.
  5. Molekuler lan histologi, ora outcome klinis. Penurunan MDA lan perbaikan pewarnaan jaringan menarik, nanging ora padha karo nylametake sikil utawa nambah kemampuan mlaku.
  6. Pemulihan VEGF parsial. VEGF mung pulih sebagian.

Peneliti nyatakake yèn perlu kohort luwih gedhé lan studi dose‑response kanggo ngonfirmasi efek lan relevansi klinis. Ora ana konflik kepentingan lan panalitungan iki wis entuk persetujuan etika kewan.

Ringkesan Praktis

  • Dosis: 20 µg/kg intraperitoneal ing tikus. Iki ora dadi patokan dosis manungsa; teknik suntikan peritoneal mung kanggo laboratorium.
  • Wektu administrasi: diwènèhi ing pungkasan fase iskemia, nalika reperfusi diwiwiti. Iki model rescue timing, ora regimen preventif.
  • Sapa sing potensial kapentingané: Peneliti lan klinisi sing sinau cedera reperfusi, komplikasi operasi vaskular, lan penyakit arteri perifer. Makalah iki bisa dadi pijakan kanggo riset praklinis sing luwih gedhé.
  • Sapa sing kudu ngindhari: Sapa wae sing ngarep‑arep ngatasi pegel otot, masalah sirkulasi, utawa cidera olahraga adhedhasar makalah iki. Wong kanthi penyakit arteri perifer, utawa sing ngalami darurat aliran darah ing sikil, kudu ngupaya perawatan medis profesional, dudu peptida sing durung disetujoni. Wong sing lagi ngandhut, nyusoni, utawa nduwèni riwayat kanker uga kudu ngindhari BPC‑157 amarga data keamanan ing manungsa durung ana, lan produk sing didol ing internet ora terverifikasi.

Kesimpulan

Studi ing tikus iki nambah sinyal praklinis yèn BPC‑157 bisa nyuda kerusakan oksidatif, inflamasi, lan apoptosis ing otot sing kena stres. Nanging, eksperimen siji dosis ing 24 tikus ora cukup kanggo mbuktèkaké manfaat ing wong. BPC‑157 durung dadi obat sing disetujoni, lan langkah sabanjuré yaiku riset klinis sing luwih ketat, dudu eksperimen DIY.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

Share XFacebookLinkedInRedditWhatsApp
NC

Written by

Nova Chen

Nova Chen writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

A wide, editorial-style still life photographed in soft natural window light on a pale oatmeal-colored linen surface. In the center foreground, a single small amber glass vial with a matte white cap sits slightly off-center to the right, unlabeled and minimal. Beside it lies a delicate, translucent skein of tendon-like fibers, rendered as fine pale ivory threads gently fanning out and twisting together, resting on a folded sheet of cream paper. To the left, a glass petri dish with a thin layer of soft blush-pink liquid, catching a subtle highlight, and a slim pair of stainless steel tweezers laid diagonally across the surface. Behind the objects, a softly blurred background in muted sage green and warm taupe suggests a quiet laboratory shelf, with out-of-focus glassware shapes and a single trailing sprig of eucalyptus adding an organic note. A thin, hand-drawn style line diagram of interconnected nodes and curved arrows, in faint terracotta ink, is printed on the paper beneath the fibers. It hints at a cellular signaling pathway without any text or readable labels. The composition uses generous negative space on the left third for potential title overlay, with a shallow depth of field and a gentle diagonal flow from the petri dish to the vial. The color palette is restrained and warm: cream, sage, blush, amber, and terracotta accents, with soft shadows and a faint film-grain texture. The mood is calm, thoughtful, and scientific but approachable, like a contemporary health and science magazine cover. Shot as if with a 50mm lens at f/2.8, top-down at a slight 30-degree angle, with crisp focus on the vial and fibers. No people, no text, no futuristic elements.
peptides

BPC‑157 lan Perbaikan Tendon: Apa sing Dituduh Riset FAK‑Paxillin lan Apa sing Ora Dituduh

BY DR. SYNAPSE ·

BPC‑157, peptida 15 asam amino sing kondhang ing kalangan “penyembuh” online, nduwèni studi 2011 sing akèh disitasi lan dadi dhasar reputasiné kanggo ndandani tendon. Peneliti nemokaké yèn peptida iki ngebut pertumbuhan fibroblas tendon, nambah kelangsungan sel nalika kahanan stres oksidatif, lan nambah migrasi sel, kamungkinan amarga ngaktifaké jalur FAK‑paxillin. Nanging ora kabukti langsung nambah proliferasi sel, lan kabèh asil iki asalé saka jaringan lan sel tikus ing laboratorium. Artikel iki nerangake mekanisme, kenapa asil kuwi ora bisa langsung diparingi makna kanggo manungsa, lan maringi gambaran babagan status regulasi peptida sing durung disetujoni.
Approach 4, conceptual metaphor, in palette D, bold color field. A single frayed tendon-like rope of braided cream fibers stretches taut across the frame, photographed at a low three-quarter angle. It is partly mended with a short, glossy section of tightly wrapped surgical suture thread. The mended section is visibly thinner and unconvincing against the thick, worn rope. The rope sits on a seamless saturated mustard-yellow backdrop, lit by one large softbox from camera left. This gives crisp, soft-edged shadows and clearly visible fiber texture. A thin electric green thread is knotted around the repair, the only green in the scene. The background is shallow and slightly out of focus on the right, leaving open space. The mood is skeptical and sober, a questionable shortcut under scrutiny, with a clean editorial feel and no text anywhere.
peptides

BPC‑157 lan TB‑500: Apa Sing Dikatakake Déning Bedah Ortopedi Saiki

BY HELIX WARD ·

Forum gym lan klinik kesejahteraan asring nyaranake BPC‑157 lan TB‑500 minangka cara cepet mari saka tatu, nanging apa sing sejatine diomongake déning dokter bedah ortopedi? Review anyar ing *Journal of the American Academy of Orthopaedic Surgeons* nemokake yèn bukti musculoskeletal manungsa kanggo BPC‑157 mung sak seri kasus cilik sing ora terkendali. TB‑500 sejatiné fragmen pitung asam amino sing asring kebingungan karo thymosin beta‑4 sing lengkap. Identitas produk, kebersihan, lan sterilisasi isih dadi pitakon sing durung terjawab, lan ora ana agen sing nduwèni indikasi musculoskeletal sing disetujoni FDA.
**Approach: Conceptual metaphor. Palette: D, bold color field.** A saturated mustard-yellow seamless backdrop. In the center, shot from a slightly high three-quarter angle, a single old brass balance scale stands on a matte surface. One pan holds a small, glossy, translucent green glass sphere with a faint electric green (#00e676) glow inside, standing for the peptide's promise. The other pan holds a plain grey stone of similar size. The beam is almost level but tilts slightly toward the green side, so the result looks real but not decisive. Hard, directional studio light from the upper left casts crisp, defined shadows across the yellow. Fine scratches and patina show on the brass. The background is clean and the framing is wide, with open space on the right. The mood is curious, skeptical and balanced.
peptides

Peptida Otak N‑PEP‑12: Peningkatan Memori Sajrone 90 Dina, Nanging Ana Gotong

BY NOVA CHEN ·

Sebuah uji acak kanthi 276 peserta sing nampa suplemen peptida N‑PEP‑12 nuduhaké yèn skor perhatian wiwit béda karo plasebo sak suwéné wektu ing wong diwasa umur 50‑75 taun sing ngeluh babagan memori lan konsentrasi. Ing 90 dina, loro grup dosis 45 mg lan 90 mg loro‑loro nuduhaké peningkatan sing luwih gedhé ing kewaspadaan, atensi lan memori, lan uga skor Digit Span sing nambah. Nanging, efek utama perawatan ora signifikan (p = 0.133) lan temuan ing titik akhir tetep dijenengi eksploratif. Efek samping jarang lan rata antar grup. Kene apa sing dituduhaké data, sapa sing cocok, lan apa sing isih durung ana.
**Approach: Lab in action. Palette: D, bold color field (teal).** Overhead three-quarter angle on a gloved hand holding a small insulin-style syringe over a tray of mouse-muscle tissue samples. The nitrile glove is bright white, and the backdrop is a saturated teal lab bench surface with a soft sheen. Tiny clear microtubes sit in a rack, and a few contain a faint amber liquid. One thin electric green cap on a tube is the only green accent. The lighting is bright, even studio-like lab light with crisp, soft-edged shadows and a gentle highlight on the syringe barrel and a single hanging droplet at the needle tip. The depth of field is shallow, so the background tubes blur into teal. The mood is precise, focused and quietly hopeful, with no readable text or labels anywhere.
peptides

Siji Suntikan Nggawe Mitokondria Otot Tikus Tuwa Aktif Kaya Muda Ing 1 Jam

BY HELIX WARD ·

Siji suntikan SS‑31 (elamipretide) bisa mulihaké produksi energi mitokondria otot tikus sing wis tuwa nganti tingkat kaya tikus enom, mung sajrone sak jam. Data iki asalé saka studi tikus 2013, dudu saka uji klinis manungsa. Peptida iki ora nuduhaké pangaruh ing otot enom, nanging nambah ketahanan sawise wolung dina pangobatan ing tikus tuwa. Ing manungsa, elamipretide wis diparingi persetujuan FDA kanggo sindrom Barth, nanging gagal nggayuh tujuan utama ing uji coba MMPOWER‑3 kanggo miopati mitokondria.

This page is available in

English العربيةবাংলাČeštinaDeutschEspañolفارسیFrançaisHausaहिन्दीHrvatskiBahasa IndonesiaItaliano日本語Basa Jawa한국어NederlandsਪੰਜਾਬੀPolskiPortuguêsRomânăРусскийSrpskiTürkçeУкраїнськаTiếng Việt中文